Truist Securities Starts ANI Pharmaceuticals (ANIP) at Buy
Truist Securities analyst Gregory Fraser initiates coverage on ANI Pharmaceuticals (NASDAQ ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)